During the past decade, Unidad Nacional de Oncologia Pediatrica conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unidad Nacional de Oncologia Pediatrica" #1 collaborator was "Johns Hopkins University" with 1 trials as a collaborator and "Tarleton State University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Unidad Nacional de Oncologia Pediatrica" are "Retinoblastoma" (2 trials), "Antibiotic Resistant Infection" (1 trials) and "Influenza, Human" (1 trials). Many other conditions were trialed in "Unidad Nacional de Oncologia Pediatrica" in a lesser frequency.

Most popular intervention types in "Unidad Nacional de Oncologia Pediatrica" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Temozolomide" (1 trials), "oseltamivir" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Unidad Nacional de Oncologia Pediatrica" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Unidad Nacional de Oncologia Pediatrica". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Unidad Nacional de Oncologia Pediatrica, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Unidad Nacional de Oncologia Pediatrica, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".